CerviCore and FlexiCore were never on the market.
In 2006, Stryker Spine conducted a human trial study on 400 patients, 200 of whom received CerviCore implants.
During that period, the manufacturer ran a separate but similar study on FlexiCore involving a similar number of patients.
Both studies failed and left numerous people injured.
Stryker Spine said it abandoned the two studies because it realized the two products were not viable.
CerviCore and FlexiCore victims allege the manufacturer agreed to monitor the health of patients with the implanted devices, but they say the company did not monitor them once it stopped conducting the studies and decided to abandon the products.
Moreover, Plaintiffs say the company has refused to provide them with continuous care.
Sadly, both devices have caused a variety of complications and injuries for patients.
In fact, most of the patients have symptoms of blood poisoning from metal, which may be caused by the two plates grinding against each other and releasing metal ions into patients’ blood and tissue.
Many people have grown very ill.
Zoll & Kranz represents those that have fallen victim to defective pharmaceutical drugs or medical devices.
If you were a participant of the CerviCore or FlexiCore trial studies, please contact our firm to learn about your potential case options by calling (419) 827-3194.
Zoll & Kranz – Defective Medical Drug and Device Lawyers